Difference between revisions of "Lestaurtinib (CEP-701)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m
 
Line 9: Line 9:
  
 
[[Category:FLT3 inhibitors]]
 
[[Category:FLT3 inhibitors]]
[[Category:JAK inhibitors]]
+
[[Category:JAK2 inhibitors]]
  
 
[[Category:Investigational drugs]]
 
[[Category:Investigational drugs]]
 
[[Category:Stub]]
 
[[Category:Stub]]

Latest revision as of 11:24, 23 September 2023

Mechanism of action

From the NCI Drug Dictionary: An orally bioavailable indolocarbazole derivative with antineoplastic properties. Lestaurtinib inhibits autophosphorylation of FMS-like tyrosine kinase 3 (FLT3), resulting in inhibition of FLT3 activity and induction of apoptosis in tumor cells that overexpress FLT3.

Also known as

  • Code name: CEP-701